Publications by authors named "A Selberherr"

Article Synopsis
  • Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) can be either hormone-secreting or non-secreting, have serious health implications, and an average survival of 75-124 months.
  • Research shows that key genes involved in the tumor's development, especially epigenetic regulators like MEN1, DAXX, and ATRX, are often mutated, but their effects are not well understood.
  • The calcium sensing receptor (CaSR) is significantly reduced in GEP-NETs, potentially due to DNA methylation and chromatin modifications, suggesting it functions as a tumor suppressor by inhibiting cell growth in pancreatic NETs.
View Article and Find Full Text PDF

RECIST 1.1 criteria are commonly used with computed tomography (CT) to evaluate the efficacy of systemic treatments in patients with neuroendocrine tumors (NETs) and liver metastases (LMs), but their relevance is questioned in this setting. We aimed to explore alternative criteria using different numbers of measured LMs and thresholds of size and density variation.

View Article and Find Full Text PDF

Background: Awareness of the potential global overtreatment of patients with appendiceal neuroendocrine tumours (NETs) of 1-2 cm in size by performing oncological resections is increasing, but the rarity of this tumour has impeded clear recommendations to date. We aimed to assess the malignant potential of appendiceal NETs of 1-2 cm in size in patients with or without right-sided hemicolectomy.

Methods: In this retrospective cohort study, we pooled data from 40 hospitals in 15 European countries for patients of any age and Eastern Cooperative Oncology Group performance status with a histopathologically confirmed appendiceal NET of 1-2 cm in size who had a complete resection of the primary tumour between Jan 1, 2000, and Dec 31, 2010.

View Article and Find Full Text PDF
Article Synopsis
  • Intraoperative spikes of parathyroid hormone (PTH) are common in patients undergoing surgery for primary hyperparathyroidism, impacting the accuracy of current monitoring methods.
  • This study analyzed 277 patients with significant PTH spikes to assess a new interpretation model using "visualization value" (VV) alongside traditional criteria (Miami and Vienna).
  • Results showed that using the VV improved sensitivity and accuracy for identifying single-gland disease cures, but missed some cases of multiple-gland disease, indicating the VV can be a helpful alternative if conditions allow.
View Article and Find Full Text PDF